The round was led by Shangbay Capital, bringing the company's total funding to date to $12.25 million. The new capital will accelerate growth of SoundHealth's portfolio of personalized, FDA-cleared therapeutics designed to treat population scale breathing; and wellness devices targeted towards sleep disorders.

SoundHealth is a medical technology company developing personalized, AI-enabled, non-invasive devices that treat population-scale breathing and sleep disorders. SoundHealth is recommended by more than 1,000 professionals nationwide.